Paracetamol Accelerates Closure of the Ductus Arteriosus after Premature Birth: A Randomized Trial

Journal of Pediatrics

Volumn 177, Issue , 2016, Pages 72-77.e2

  Härkin, Pia ^a   Härmä, Antti ^a   Aikio, Outi ^a   Valkama, Marita ^a   Leskinen, Markku ^a   Saarela, Timo ^a   Hallman, Mikko ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

acetaminophen; intravenous; patent ductus arteriosus; preterm infant

Indexed keywords

PARACETAMOL; PLACEBO; ANALGESIC AGENT;

ABSENCE OF SIDE EFFECTS; BIOLOGICAL ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUCTUS ARTERIOSUS; FEMALE; FOLLOW UP; GESTATIONAL AGE; HUMAN; INFANT; INTRACARDIAC ECHOCARDIOGRAPHY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NEONATAL INTENSIVE CARE UNIT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND; CLINICAL TRIAL; DUCTUS ARTERIOSUS, PATENT; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; TREATMENT OUTCOME; VERY LOW BIRTH WEIGHT;

ACETAMINOPHEN; ADMINISTRATION, INTRAVENOUS; ANALGESICS, NON-NARCOTIC; DOUBLE-BLIND METHOD; DUCTUS ARTERIOSUS, PATENT; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MALE; PREMATURE BIRTH; TREATMENT OUTCOME;

EID: 84969549298     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2016.04.066     Document Type: Conference Paper

References (37)

1. 1 Hamrick, S.E., Hansmann, G., Patent ductus arteriosus of the preterm infant. Pediatrics 125 (2010), 1020–1030.
2. 2 Noori, S., McCoy, M., Friedlich, P., Bright, B., Gottipati, V., Seri, I., et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics 123 (2009), e138–e144.
3. 3 Rolland, A., Shankar-Aguilera, S., Diomande, D., Zupan-Simunek, V., Boileau, P., Natural evolution of patent ductus arteriosus in the extremely preterm infant. Arch Dis Child Fetal Neonatal Ed 100 (2015), F55–F58.
4. 4 Clyman, R.I., Chorne, N., Patent ductus arteriosus: evidence for and against treatment. J Pediatr 150 (2007), 216–219.
5. 5 Zonnenberg, I., de, W.K., The definition of a haemodynamic significant duct in randomized controlled trials: a systematic literature review. Acta Paediatr 101 (2012), 247–251.
6. 6 Heuchan, A.M., Clyman, R.I., Managing the patent ductus arteriosus: current treatment options. Arch Dis Child Fetal Neonatal Ed 99 (2014), F431–F436.
7. 7 Mirea, L., Sankaran, K., Seshia, M., Ohlsson, A., Allen, A.C., Aziz, K., et al. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr 161 (2012), 689–694.
8. 8 Sosenko, I.R., Fajardo, M.F., Claure, N., Bancalari, E., Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr 160 (2012), 929–935.
9. 9 Gournay, V., Roze, J.C., Kuster, A., Daoud, P., Cambonie, G., Hascoet, J.M., et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet 364 (2004), 1939–1944.
10. 10 Kluckow, M., Jeffery, M., Gill, A., Evans, N., A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 99 (2014), F99–F104.
11. 11 Ohlsson, A., Shah, S.S., Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev(7), 2011, CD004213.
12. 12 Schmidt, B., Davis, P., Moddemann, D., Ohlsson, A., Roberts, R.S., Saigal, S., et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 344 (2001), 1966–1972.
13. 13 Anderson, B.J., Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth 18 (2008), 915–921.
14. 14 Harma, A., Aikio, O., Hallman, M., Saarela, T., Intravenous paracetamol decreases requirements of morphine in very preterm infants. J Pediatr 168 (2016), 36–40.
15. 15 El-Khuffash, A., James, A.T., Cleary, A., Semberova, J., Franklin, O., Miletin, J., Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Arch Dis Child Fetal Neonatal Ed 100 (2015), F253–F256.
16. 16 Hammerman, C., Bin-Nun, A., Markovitch, E., Schimmel, M.S., Kaplan, M., Fink, D., Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 128 (2011), e1618–e1621.
17. 17 Oncel, M.Y., Yurttutan, S., Erdeve, O., Uras, N., Altug, N., Oguz, S.S., et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 164 (2014), 510–514.
18. 18 Aikio, O., Harkin, P., Saarela, T., Hallman, M., Early paracetamol treatment associated with lowered risk of persistent ductus arteriosus in very preterm infants. J Matern Fetal Neonatal Med 27 (2014), 1252–1256.
19. 19 European Medicines Agency. Guideline for Good Clinical Practice. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/08/WC500191488.pdf. Accessed July 23, 2015.
20. 20 Polkki, T., Korhonen, A., Axelin, A., Saarela, T., Laukkala, H., Development and preliminary validation of the Neonatal Infant Acute Pain Assessment Scale (NIAPAS). Int J Nurs Stud 51 (2014), 1585–1594.
21. 21 Skinner, J., Alverson, D., Hunter, S., Echocardiography for the neonatologist. 2000, Churchill Livingstone, London.
22. 22 Ehrenkranz, R.A., Walsh, M.C., Vohr, B.R., Jobe, A.H., Wright, L.L., Fanaroff, A.A., et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116 (2005), 1353–1360.
23. 23 Papile, L.A., Burstein, J., Burstein, R., Koffler, H., Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 92 (1978), 529–534.
24. 24 Bell, M.J., Ternberg, J.L., Feigin, R.D., Keating, J.P., Marshall, R., Barton, L., et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187 (1978), 1–7.
25. 25 International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123 (2005), 991–999.
26. 26 Fowlie, P.W., Davis, P.G., McGuire, W., Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev(7), 2010, CD000174.
27. 27 Ohlsson, A., Shah, P.S., Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants. Cochrane Database Syst Rev, 3, 2015, CD010061.
28. 28 Oncel, M.Y., Yurttutan, S., Degirmencioglu, H., Uras, N., Altug, N., Erdeve, O., et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 103 (2012), 165–168.
29. 29 Clyman, R.I., Mechanisms regulating the ductus arteriosus. Biol Neonate 89 (2006), 330–335.
30. 30 Echtler, K., Stark, K., Lorenz, M., Kerstan, S., Walch, A., Jennen, L., et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nat Med 16 (2010), 75–82.
31. 31 Allegaert, K., Palmer, G.M., Anderson, B.J., The pharmacokinetics of intravenous paracetamol in neonates: size matters most. Arch Dis Child 96 (2011), 575–580.
32. 32 El-Khuffash, A., Jain, A., Corcoran, D., Shah, P.S., Hooper, C.W., Brown, N., et al. Efficacy of paracetamol on patent ductus arteriosus closure may be dose dependent: evidence from human and murine studies. Pediatr Res 76 (2014), 238–244.
33. 33 Allegaert, K., Rayyan, M., De, R.T., Van, B.F., Naulaers, G., Hepatic tolerance of repeated intravenous paracetamol administration in neonates. Paediatr Anaesth 18 (2008), 388–392.
34. 34 Allegaert, K., Naulaers, G., Haemodynamics of intravenous paracetamol in neonates. Eur J Clin Pharmacol 66 (2010), 855–858.
35. 35 Chiam, E., Weinberg, L., Bailey, M., McNicol, L., Bellomo, R., The haemodynamic effects of intravenous paracetamol (acetaminophen) in healthy volunteers: a double-blind, randomized, triple crossover trial. Br J Clin Pharmacol 81 (2016), 605–612.
36. 36 Porta, R., Sanchez, L., Nicolas, M., Garcia, C., Martinez, M., Lack of toxicity after paracetamol overdose in an extremely preterm neonate. Eur J Clin Pharmacol 68 (2012), 901–902.
37. 37 Aikio, O., Metsola, J., Vuolteenaho, R., Perhomaa, M., Hallman, M., Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. J Pediatr 161 (2012), 397–403.